Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons
Open Access
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (9) , 1574-1584
- https://doi.org/10.1038/mt.2009.142
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph DiseasePLOS ONE, 2008
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAiProceedings of the National Academy of Sciences, 2008
- Unexpected off-targeting effects of anti-huntingtin ribozymes and siRNA in vivoNeurobiology of Disease, 2008
- Adeno-associated virus-mediated knockdown of melanocortin-4 receptor in the paraventricular nucleus of the hypothalamus promotes high-fat diet-induced hyperphagia and obesityJournal of Endocrinology, 2008
- Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndromeProceedings of the National Academy of Sciences, 2007
- An investigation of the problem of two-layered immunohistochemical staining in paraformaldehyde fixed sectionsJournal of Neuroscience Methods, 2006
- Leptin Receptor Signaling in Midbrain Dopamine Neurons Regulates FeedingNeuron, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic miceMolecular Therapy, 2005
- Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal SystemJournal of Neuroscience, 2000